197 related articles for article (PubMed ID: 19797521)
1. Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition.
de Larrea CF; Cibeira MT; Elena M; Arostegui JI; Rosiñol L; Rovira M; Filella X; Yagüe J; Bladé J
Blood; 2009 Dec; 114(24):4954-6. PubMed ID: 19797521
[TBL] [Abstract][Full Text] [Related]
2. Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of novel agents.
Fernández de Larrea C; Tovar N; Cibeira MT; Aróstegui JI; Rosiñol L; Elena M; Filella X; Yagüe J; Bladé J
Haematologica; 2011 Jan; 96(1):171-3. PubMed ID: 20884709
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation.
Alejandre ME; Pavlovsky MA; Remaggi G; Corrado C; Fernandez I; Milone G; Pavlovsky A; Madalena L; Pandolfo M; Facio ML; Bresciani P; Pavlovsky S; Pizzolato MA
Clin Chem Lab Med; 2012 Apr; 50(6):1093-7. PubMed ID: 22706252
[TBL] [Abstract][Full Text] [Related]
4. oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survival.
Fujisawa M; Seike K; Fukumoto K; Suehara Y; Fukaya M; Sugihara H; Takeuchi M; Matsue K
Cancer Sci; 2014 Nov; 105(11):1442-6. PubMed ID: 25182124
[TBL] [Abstract][Full Text] [Related]
5. Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.
Tovar N; de Larrea CF; Aróstegui JI; Cibeira MT; Rosiñol L; Rovira M; Elena M; Filella X; Yagüe J; Bladé J
Haematologica; 2013 Jul; 98(7):1142-6. PubMed ID: 23645688
[TBL] [Abstract][Full Text] [Related]
6. Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse.
Radocha J; Pour L; Pika T; Maisnar V; Špička I; Gregora E; Krejčí M; Minařík J; Machálková K; Straub J; Pavlíček P; Hájek R; Žák P
Eur J Haematol; 2016 Feb; 96(2):119-27. PubMed ID: 25816709
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation.
Tovar N; Fernández de Larrea C; Elena M; Cibeira MT; Aróstegui JI; Rosiñol L; Filella X; Yagüe J; Bladé J
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1076-9. PubMed ID: 22430087
[TBL] [Abstract][Full Text] [Related]
8. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
[TBL] [Abstract][Full Text] [Related]
9. Oligoclonal reconstitution masquerading as myeloma relapse.
Chim CS; Chan EY
Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
[No Abstract] [Full Text] [Related]
10. [The Clinical Significance of Oligoclonal Bands in Patient with Multiple Myeloma].
Liu JH; Fan HS; Yan WQ; Xu JY; Li LN; Xu Y; Yi SH; Zou DH; Qiu LG; An G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1453-1463. PubMed ID: 36208249
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.
Jimenez-Zepeda VH; Reece DE; Trudel S; Franke N; Winter A; Chen C; Tiedemann R; Kukreti V
Leuk Lymphoma; 2014 Oct; 55(10):2284-9. PubMed ID: 24354684
[TBL] [Abstract][Full Text] [Related]
12. The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains.
Pratt G; Mead GP; Godfrey KR; Hu Y; Evans ND; Chappell MJ; Lovell R; Bradwell AR
Leuk Lymphoma; 2006 Jan; 47(1):21-8. PubMed ID: 16321823
[TBL] [Abstract][Full Text] [Related]
13. Significance of oligoclonal bands after stem cell transplantation in multiple myeloma cases.
Liu AJ; Zong H; Yang GZ; Zhai YH; Li LH
Asian Pac J Cancer Prev; 2012; 13(4):1483-6. PubMed ID: 22799352
[TBL] [Abstract][Full Text] [Related]
14. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.
Mösbauer U; Ayuk F; Schieder H; Lioznov M; Zander AR; Kröger N
Haematologica; 2007 Feb; 92(2):275-6. PubMed ID: 17296589
[TBL] [Abstract][Full Text] [Related]
15. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
Jung S; Kim M; Lim J; Kim Y; Han K; Min CK; Min WS
Korean J Lab Med; 2008 Jun; 28(3):169-73. PubMed ID: 18594166
[TBL] [Abstract][Full Text] [Related]
16. For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission.
Silva LSVD; Crusoe EQ; Souza LRG; Chiattone CS; Hungria VTM
Rev Bras Hematol Hemoter; 2017; 39(4):331-336. PubMed ID: 29150105
[TBL] [Abstract][Full Text] [Related]
17. Questionable role of free light chain assay ratio to determine stringent complete remission in multiple myeloma patients.
Kröger N; Asenova S; Gerritzen A; Bacher U; Zander A
Blood; 2010 Apr; 115(16):3413-4; author reply 3414-5. PubMed ID: 20413663
[No Abstract] [Full Text] [Related]
18. Lack of correlation between emergence of an abnormal protein band or of oligoclonal bands and survival in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation.
Byrne E; Giles C; Andrews J; Rahemtulla A; Naresh KN
Haematologica; 2011 Apr; 96(4):e29. PubMed ID: 21454876
[No Abstract] [Full Text] [Related]
19. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G
J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
[TBL] [Abstract][Full Text] [Related]
20. Heavy/light chain assay in the monitoring of multiple myeloma.
Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]